全球医学影像模型市场规模（按产品类型、材料、最终用户、区域范围和预测）

医学影像模型的市场规模及预测

2024 年医学影像模型市场规模价值为 559.7 亿美元，预计到 2032 年将达到 839.6 亿美元，预测期内（2026-2032 年）的复合年增长率为 5.20%。

心臟衰竭衰竭、慢性肾臟病和慢性阻塞性肺病(COPD) 等文明病导致的疾病负担日益加重，以及对高效影像诊断程序所需的精确校准技术的需求日益增长，这些因素极大地推动了全球医学影像模型市场的成长。本研究报告对全球医学影像模型市场进行了全面评估，并对关键细分市场、趋势、市场驱动因素、竞争格局以及影响市场的关键因素进行了全面的分析。

推动全球医学影像模型市场的因素

医学影像模型市场的市场驱动力可能受到多种因素的影响，其中包括：

诊断影像需求日益增长：随着癌症、心血管疾病、神经系统疾病等慢性疾病的发生率不断上升，对诊断影像治疗的需求也日益增长。医学影像模型在影像系统的校准和准确性保证中发挥着至关重要的作用，这满足了对精确诊断设备日益增长的需求。

显像模式的技术发展：CT、MRI、超音波和核子医学等影像技术的进步正在推动对先进体模的需求。体模可用于测试新的成像方法、改进通讯协定以及检验复杂成像系统的功能。

日益重视辐射安全：辐射安全在医学影像中日益重要。体模有助于准确估算剂量，简化成像技术，从而减少不必要的辐射暴露，对于评估和限制患者的辐射暴露至关重要。

监管要求与品质保证 医学影像设备的品质保证必须符合欧洲药品管理局 (EMA) 和美国食品药物管理局(FDA) 等监管机构制定的严格准则。体模是遵守这些法规并确保成像系统产生可靠且统一结果的关键设备。

数位成像系统日益普及：医疗机构在从类比成像系统过渡到数位成像系统的过程中，需要使用模型进行验证和校准。由于数位成像系统需要定期进行品质测试以保持影像品质和诊断准确性，因此模型的需求量很大。

全球医疗保健领域的扩张：全球医疗保健产业的扩张，尤其是在新兴市场，带动了先进医学影像技术的使用成长。新建的医疗机构对成像模型的需求日益增长，以确保成像设备的正常运作和准确性。

医学影像模型：广泛用于实验室和教育机构的培训和研究，使研究人员和学生能够在安全的环境中试验和开发新的影像模式，而不会让病患面临不必要的风险。

人口老化：随着世界人口老化，与老龄化相关的疾病的发生率也随之上升，对医学影像检查的需求也随之增加。模体对于维持用于识别和追踪这些情况的成像系统的准确性和可靠性至关重要。

客製化患者专用模型：3D 列印和材料科学的发展使得创建客製化患者专用模型成为可能，旨在模拟特定的解剖特征和疾病，从而可以对成像系统进行更准确和个性化的测试。

伙伴关係与协作：研究中心、影像设备製造商和医疗保健提供者的创新努力，为新型增强型体模的开发提供了支持。这些协作对于影像技术的发展和体模性能的提升至关重要。

限制全球医学影像模型市场的因素

医学影像模型市场面临诸多限制和挑战，其中包括：

昂贵的体模成本：医学影像体模所使用的材料及其製造所需的精度水准使得其价格昂贵。小型医疗机构、研究机构和教育机构无力购买和使用如此昂贵的体模。

普及度和认知度有限：使用医学影像模型的益处和意义尚不为人所知，尤其是在开发中国家。因此，医疗保健提供者可能不会优先购买用于影像校准和检验的模型，这可能导致其采用率较低。

技术复杂性与维护：为了获得准确、实用的结果，使用体模需要高阶技术力。此外，维护和校准体模可能既困难又耗时，这给技术人员和资源有限的设施带来了问题。

法规与合规难题：儘管法规鼓励使用体模，但这些法规的协商可能既困难又耗时。医学成像体模的製造商和使用者可能难以确保符合不同地区的各种监管标准。

使用寿命有限且需要更换：随着时间的推移，医学影像模型会因材料劣化和磨损而失去效用，需要定期更换，从而增加总体费用并给医疗机构和研究机构带来财务负担。

替代技术：电脑模拟和其他数位工具是可用于校准和检验成像系统的替代技术和方法的范例。如果消费者在某些情况下选择这些替代方案而非实体体模，这可能会减少对传统体模产品的需求。

资金限制：医疗产业的资金限制和景气衰退可能会影响对医学影像模型及其他创新技术的投资。资金限制和预算短缺可能会迫使医疗机构优先考虑其他事项，而不是购买和维护模式。

缺乏标准化：缺乏针对医学影像体模创建和应用的全球性指南，可能导致性能和品质参差不齐。标准化的缺乏使得跨多个研究和中心的数据难以比较，阻碍了体模的普遍应用。

在某些领域，先进成像技术的采用进展缓慢。在先进影像技术采用缓慢的地区，对匹配体模的需求也较低。这可能是由于教育、基础设施、经济等方面的障碍阻碍了先进影像技术的广泛应用。

环境和材料限制：医学影像体模的生产可能受到供应链和环境限制的影响，这取决于材料。这些材料的成本、可用性及其对环境的影响都会影响体模的生产和成本。

目录

第一章 全球医学影像模型市场介绍

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章 医学影像模型的全球市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章全球医学影像模型市场（依产品类型）

• 概述
• X射线模型
• MRI体模
• 核医学影像模型
• 超音波体模
• CT体模
• 其他的

6. 全球医学影像模型市场（按材料）

• 概述
• 刺激器
• 假器官

第七章全球医学影像模型市场（按最终用户）

• 概述
• 医院
• 诊断与参考实验室
• 学术和研究机构
• 医疗设备製造商
• 其他的

8. 全球医学影像模型市场：区域分析

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 其他的
  • 拉丁美洲
  • 中东和非洲

第九章医学影像模型市场的全球竞争格局

• 概述
• 各公司市场排名
• 重点发展策略

第十章 公司简介

• Biodex Medical Systems, Inc.
• Gold Standard Phantoms
• PTW Freiburg GmbH
• Carville Limited.
• Computerized Imaging Reference Systems, Inc.
• Pure Imaging Phantoms
• Dielectric Corporation
• Kyoto Kagaku Co., Ltd.
• Modus Medical Devices Inc.
• PhantomX

第十一章 重大进展

• 产品发布/开发
• 合併与收购
• 业务扩展
• 伙伴关係与合作

第十二章 附录

• 相关报告

Medical Imaging Phantoms Market Size And Forecast

Medical Imaging Phantoms Market size was valued at USD 55.97 Billion in 2024 and is projected to reach USD 83.96 Billion By 2032, growing at a CAGR of 5.20% during the forecast period 2026 to 2032.

The rising disease burden of lifestyle-related disorders such as cardiac failure, chronic kidney disease, and Chronic Obstructive Pulmonary Disease (COPD) and the increasing demand for accurate calibration techniques for effective diagnostic imaging procedures are driving the growth of the Global Medical Imaging Phantoms market significantly. The Global Medical Imaging Phantoms Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Medical Imaging Phantoms Market Drivers

The market drivers for the Medical Imaging Phantoms Market can be influenced by various factors. These may include:

Growing Need for Diagnostic Imaging: The need for diagnostic imaging treatments is being driven by the increased prevalence of chronic diseases like cancer, cardiovascular disease, and neurological disorders. Medical imaging phantoms play a crucial role in the calibration and accuracy assurance of imaging systems, which in turn supports the increasing demand for accurate diagnostic instruments.

Technological Developments in Imaging Modalities: As imaging technologies such as CT, MRI, ultrasound, and nuclear medicine continue to progress, there is an increasing demand for sophisticated phantoms. Phantoms are needed in order to test novel imaging methods, improve protocols, and verify the functionality of complex imaging systems as a result of these improvements.

Growing Concern for Radiation Safety: In medical imaging, radiation safety is becoming more and more important. By facilitating precise dose estimations and streamlining imaging techniques to cut down on needless exposure, phantoms are essential for evaluating and limiting radiation exposure to patients.

Regulatory Requirements and Quality Assurance: Medical imaging equipment quality assurance must meet strict guidelines set by regulatory organisations like the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA). Phantoms are vital instruments for adhering to these rules, guaranteeing that imaging systems generate dependable and uniform outcomes.

Growing Adoption of Digital Imaging Systems: In healthcare institutions, the transition from analogue to digital imaging systems requires the usage of phantoms for validation and calibration. Phantoms are in high demand because digital imaging systems need to undergo routine quality tests to preserve image quality and diagnostic accuracy.

Global Healthcare Sector Expansion: The use of advanced medical imaging technologies is rising as a result of the global healthcare sector's expansion, especially in emerging markets. The need for imaging phantoms to guarantee the correct operation and precision of imaging equipment in recently constructed healthcare facilities is increased by this expansion.

Medical imaging phantoms: are extensively utilised for training and research reasons in research labs and educational establishments. They give researchers and students a secure setting in which to experiment and create novel imaging methods without putting patients at needless danger.

Ageing Population: As the world's population ages, the prevalence of age-related illnesses is rising, which in turn raises demand for medical imaging tests. Phantoms are essential to maintaining the precision and dependability of imaging systems that are used to identify and track these circumstances.

Customised and Patient-Specific Phantoms: The creation of customised and patient-specific phantoms has been made possible by developments in 3D printing and materials science. With the use of these phantoms, imaging systems may be tested more precisely and individually because they are designed to mimic particular anatomical features and diseases.

Partnerships and Collaborations: The development of new and enhanced phantoms is being aided by the innovative work of research centres, imaging equipment manufacturers, and healthcare providers. These collaborations are critical to the development of imaging technology and the improvement of phantom capabilities.

Global Medical Imaging Phantoms Market Restraints

Several factors can act as restraints or challenges for the Medical Imaging Phantoms Market. These may include:

Expensive Cost of Phantoms: The materials used and the level of accuracy needed during production make medical imaging phantoms costly. Smaller healthcare facilities, research institutes, and educational organisations may find it difficult to purchase and make substantial use of these phantoms because to their high cost.

Limited Adoption and Awareness: The advantages and significance of employing medical imaging phantoms are not well known in some areas, particularly in developing nations. Healthcare providers might not prioritise purchasing phantoms for imaging calibration and validation as a result, which could result in lower adoption rates.

Technical Complexity and Maintenance: In order to achieve precise and useful results, using phantoms may require a high level of technical competence. Furthermore, these phantoms can be difficult and time-consuming to maintain and calibrate, which presents problems for institutions with little technical staff or funding.

Regulatory and Compliance Difficulties: Although phantom use is encouraged by rules, negotiating these regulations can be difficult and time-consuming. Manufacturing companies and users of medical imaging phantoms may find it difficult to ensure compliance with various regulatory standards in various geographical areas.

Limited Lifespan and Replacement Needs: Over time, material degradation or wear and tear can cause medical imaging phantoms to lose their usefulness. Regular replacement may be necessary, raising overall expenses and placing a financial strain on medical facilities and research institutes.

Alternative Techniques and Technologies: Computer simulations and other digital tools are examples of alternative techniques and technologies that can be used for imaging system calibration and validation. The demand for conventional phantom products may decline if consumers choose these substitutes for tangible phantoms in certain situations.

Financial Restraints: Investments in medical imaging phantoms and other innovative technologies may be impacted by financial restraints and downturns in the healthcare industry. Financial strains and budget shortages may force medical facilities to put other priorities ahead of buying and maintaining phantoms.

Lack of Standardisation: Variability in performance and quality might result from the absence of global guidelines for the creation and application of medical imaging phantoms. This lack of standardisation can make it difficult to compare data across many studies and institutions and impede the general adoption of phantoms.

Advanced Imaging Technologies Are Adopted Slowly in Certain Areas: There is also less of a need for matching phantoms in areas where the uptake of cutting-edge imaging technologies is sluggish. This may be the result of obstacles relating to education, infrastructure, or the economy that keep advanced imaging modalities from being widely used.

Environmental and Material Constraints: Certain materials may be subject to supply chain or environmental restrictions during the manufacturing of medical imaging phantoms. The cost, availability, and environmental effects of these materials can all have an impact on phantom manufacturing and cost.

Global Medical Imaging Phantoms Market Segmentation Analysis

The Global Medical Imaging Phantoms Market is Segmented on the basis of Product Type, Material, End-User, And Geography.

Medical Imaging Phantoms Market, By Product Type

• X-ray Phantoms
• MRI Phantoms
• Nuclear Imaging Phantoms
• Ultrasound Phantoms
• CT Phantoms

Based on Product Type, The market is segmented into X-ray Phantoms, MRI Phantoms, Nuclear Imaging Phantoms, Ultrasound Phantoms, CT Phantoms, and Others. The X-ray phantoms segment accounts for the highest revenue share of the Global Medical Imaging Phantoms Market in 2020 and is expected to dominate the market over the forecast period owing to their wide applications in medical imaging procedures, including radiography, mammography, and angiography. The increasing adoption of new X-ray machines and imaging device applications and initiatives taken by the government and non-profit organizations to create awareness of the available imaging techniques are expected to drive demand for X-ray phantoms over the forecast period.

Medical Imaging Phantoms Market, By Material

• Stimulating Devices
• False Organs

Based on Material, The market is segmented into Stimulating Devices, False Organs. The stimulating devices segment is expected to hold the largest revenue share of the Global Medical Imaging Phantoms Market during the forecast period owing to the increasing usage and growing adoption of the stimulating devices for brain, lung, and cancer diagnoses have further driven the market growth of this segment.

Global Medical Imaging Phantoms Market, By End-User

• Hospitals
• Diagnostic and Reference Laboratories
• Academic and Research Institutes
• Medical Device Companies

Based on End -User, The market is bifurcated into Hospitals, Diagnostic and Reference Laboratories, Academic and Research Institutes, Medical Device Companies and Others. The hospitals segment is expected to grow at the highest CAGR during the forecast period owing to the increasing number of patients suffering from various chronic disorders along with lifestyle diseases, and raising public awareness about these disorders. Additionally, well-established healthcare infrastructure, availability of various diagnostics and treatment facilities, higher purchasing power, and the presence of highly skilled healthcare professionals are driving the growth of the Market in the hospital's segment.

Medical Imaging Phantoms Market, By Geography

• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• Latin America
• On the basis of Geography, The Global Medical Imaging Phantoms Market is classified into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America. Among the regional markets, North America accounts for the largest revenue share in Global Medical Imaging Phantoms Market in 2020 and is expected to retain its dominance throughout the forecast period. The revenue growth in the North American market is mainly attributed to the increased investment in R&D activities for the development of technologically advanced medical devices for the diagnosis of various chronic disorders along with lifestyle diseases.
• Additionally, the increasing geriatric population, rising incidence and prevalence of various chronic disorders, rising healthcare sectors, presence of skilled professionals, and wide availability of technologically advanced Medical Imaging Phantoms are the major factors that boost in the region. The market in the Asia Pacific is projected to witness expansion at a significant growth rate during the forecast period, owing to the increasing focus on the development of healthcare infrastructure and the rising prevalence of various chronic disorders such as COPD and Chronic Kidney Disease (CKD) along with lifestyle diseases in the developing nations such as China, and India in this region.

Key Players

The "Global Medical Imaging Phantoms Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as Biodex Medical Systems, Inc., Gold Standard Phantoms, PTW Freiburg GmbH, Carville Limited., Computerized Imaging Reference Systems, Inc., Pure Imaging Phantoms, Dielectric Corporation, Kyoto Kagaku Co., Ltd., Modus Medical Devices Inc., PhantomX, among others.The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL MEDICAL IMAGING PHANTOMS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL MEDICAL IMAGING PHANTOMS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL MEDICAL IMAGING PHANTOMS MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 X-ray Phantoms
• 5.3 MRI Phantoms
• 5.4 Nuclear Imaging Phantoms
• 5.5 Ultrasound Phantoms
• 5.6 CT Phantoms
• 5.7 Others

6 GLOBAL MEDICAL IMAGING PHANTOMS MARKET, BY MATERIAL

• 6.1 Overview
• 6.2 Stimulating Devices
• 6.3 False Organs

7 GLOBAL MEDICAL IMAGING PHANTOMS MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Diagnostic and Reference Laboratories
• 7.4 Academic and Research Institutes
• 7.5 Medical Device Companies
• 7.6 Others

8 GLOBAL MEDICAL IMAGING PHANTOMS MARKET: GEOGRAPHICAL ANALYSIS

• 8.1 Overview
• 8.2 North America
  • 8.2.1 The U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 The U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL MEDICAL IMAGING PHANTOMS MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Biodex Medical Systems, Inc.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Gold Standard Phantoms
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 PTW Freiburg GmbH
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Carville Limited.
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Computerized Imaging Reference Systems, Inc.
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Pure Imaging Phantoms
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Development
• 10.7 Dielectric Corporation
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Kyoto Kagaku Co., Ltd.
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Modus Medical Devices Inc.
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 PhantomX
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1.1 Related Reports